Evidence map›Paper›PMID 29523850›Full record

ArticleNature communications2018

Risk of nontyphoidal Salmonella bacteraemia in African children is modified by STAT4.

James J Gilchrist, Anna Rautanen, Benjamin P Fairfax, Tara C Mills, Vivek Naranbhai, Holly Trochet, Matti Pirinen, Esther Muthumbi, Salim Mwarumba, Patricia Njuguna and 12 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. IFNγ in human sepsis: a scoping review.Annals of intensive care · 2025
    Review
  3. Article
  4. Tropical medicine and infectious disease · 2023
    Review
  5. The Prolonged Treatment ofInternational journal of molecular sciences · 2023
    Article
  6. Article
  7. eLife · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. AlteredFrontiers in immunology · 2021
    Article
  13. Pathogenic signature of invasive non-typhoidalHuman vaccines & immunotherapeutics · 2020
    Review
  14. Article
  15. HumanClinical & translational immunology · 2020
    Article
  16. Article
  17. Review
  18. Review
  19. Invasive NontyphoidalEcoSal Plus · 2019
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 4 countries.

James J GilchristWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK. james.gilchrist@well.ox.ac.uk.ORCID http://orcid.org/0000-0003-2045-6788
Anna RautanenWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
Benjamin P FairfaxWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
Tara C MillsWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
Vivek NaranbhaiWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.ORCID http://orcid.org/0000-0003-4281-8882
Holly TrochetWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
Matti PirinenWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.ORCID http://orcid.org/0000-0002-1664-1350
Esther MuthumbiKEMRI-Wellcome Trust Research Programme, Kilifi, 80108, Kenya.
Salim MwarumbaKEMRI-Wellcome Trust Research Programme, Kilifi, 80108, Kenya.
Patricia NjugunaKEMRI-Wellcome Trust Research Programme, Kilifi, 80108, Kenya.
Neema MturiKEMRI-Wellcome Trust Research Programme, Kilifi, 80108, Kenya.
Chisomo L MsefulaMalawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, P.O. Box 30096, Chichiri, Blantyre, Malawi.
Esther N GondweMalawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, P.O. Box 30096, Chichiri, Blantyre, Malawi.
Jenny M MacLennanMalawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, P.O. Box 30096, Chichiri, Blantyre, Malawi.
Stephen J ChapmanWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
Malcolm E MolyneuxMalawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, P.O. Box 30096, Chichiri, Blantyre, Malawi.
Julian C KnightWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
Chris C A SpencerWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
Thomas N WilliamsKEMRI-Wellcome Trust Research Programme, Kilifi, 80108, Kenya.
Calman A MacLennanMalawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, P.O. Box 30096, Chichiri, Blantyre, Malawi.
J Anthony G ScottKEMRI-Wellcome Trust Research Programme, Kilifi, 80108, Kenya.ORCID http://orcid.org/0000-0001-7533-5006
Adrian V S HillWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK. adrian.hill@ndm.ox.ac.uk.ORCID http://orcid.org/0000-0003-0900-9629
Centre for Human Genetics · GBKenya Medical Research Institute · KEUniversity of Liverpool · GBUniversity of London · GB

Funding

European Research Council 294557Medical Research Council G0900747Medical Research Council G1001712Medical Research Council MR/P008852/1Wellcome Trust 201488/Z/16/Z
6 · The paper itself

Abstract

Nontyphoidal Salmonella (NTS) is a major cause of bacteraemia in Africa. The disease typically affects HIV-infected individuals and young children, causing substantial morbidity and mortality. Here we present a genome-wide association study (180 cases, 2677 controls) and replication analysis of NTS bacteraemia in Kenyan and Malawian children. We identify a locus in STAT4, rs13390936, associated with NTS bacteraemia. rs13390936 is a context-specific expression quantitative trait locus for STAT4 RNA expression, and individuals carrying the NTS-risk genotype demonstrate decreased interferon-γ (IFNγ) production in stimulated natural killer cells, and decreased circulating IFNγ concentrations during acute NTS bacteraemia. The NTS-risk allele at rs13390936 is associated with protection against a range of autoimmune diseases. These data implicate interleukin-12-dependent IFNγ-mediated immunity as a determinant of invasive NTS disease in African children, and highlight the shared genetic architecture of infectious and autoimmune disease.

Indexed as

Genetic Predisposition to DiseaseAdolescentAllelesAutoimmune DiseasesBacteremiaCase-Control StudiesChildChild, PreschoolFemaleFollow-Up StudiesGenome-Wide Association StudyGenotypeHumansImmunity, CellularInfantInfant, NewbornInterferon-gammaInterleukin-12STAT4 protein, humanSTAT4 Transcription Factor

Identifiers

PMID29523850
PMCPMC5844948
OpenAlexW2792442926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.